A White House official said the administration will open public comment “hopefully very soon” on a plan to allow buprenorphine to be prescribed via telemedicine through a waiver initiated under the opioid public health emergency, coming as stakeholders appear to face an uphill battle in getting Congress to extend a COVID-19 pandemic waiver of the Ryan Haight law’s in-person prescribing requirements for controlled substances.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us